Clinical Trials Logo
  1. Home
  2. Urinary Bladder, Neurogenic
  3. NCT01557244

A Study To Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition

Urinary Bladder, Neurogenic Clinical Trial

Official title:
A 24-WEEK RANDOMIZED, OPEN-LABEL, STUDY TO EVALUATE THE SAFETY AND EFFICACY OF FESOTERODINE IN SUBJECTS AGED 6 TO 17 YEARS WITH SYMPTOMS OF DETRUSOR OVERACTIVITY ASSOCIATED WITH A NEUROLOGICAL CONDITION (NEUROGENIC DETRUSOR OVERACTIVITY)

Clinical Trial Summary

The objective of the study is to find out if the medicine fesoterodine is a useful treatment in children with bladder muscle overactivity caused by a neurological condition. Children will be aged 6 to 17 years old. This is done by finding out how well it works, what the body does to fesoterodine, what side effects are experienced and the safety of fesoterodine. It will be compared with the medicine oxybutynin, which is already available for treating the condition.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01557244
Study type Interventional
Source Pfizer
Contact
Status Completed
Phase Phase 3
Start date July 2, 2012
Completion date February 13, 2020
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05141487 - Feasibility of Triggered Sacral Neuromodulation for Neurogenic Bladder
Completed NCT01920243 - Evaluation of a Bowel and Bladder Health Management Program for Individuals With Spinal Cord Injury (SCI) N/A
Completed NCT04528784 - Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis N/A
Enrolling by invitation NCT03336424 - Urinary Disorders in Patients With Multiple Sclerosis: Invasive Vs Non-invasive Investigations. N/A
Not yet recruiting NCT05075642 - Multicenter Observational Study for the Evaluation in Clinical Practice of Urinary Disorders in Multiple Sclerosis
Completed NCT02600715 - Reduction of Bladder Injection Pain With Belladonna Opiate Suppository Phase 4
Recruiting NCT04128709 - Measurement of Bladder Pressure With a Novel External Device (Cystomanometer) - Home Use N/A
Not yet recruiting NCT06336304 - NXT Post-Market Clinical Follow-up
Enrolling by invitation NCT05740527 - Ambulatory Closed-loop Stimulation for Bladder Control N/A
Completed NCT02501928 - Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity. Phase 3
Recruiting NCT04819360 - Botulinum Toxin A vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients With Multiple Sclerosis Phase 4
Terminated NCT02044510 - Urodynamic and Clinical Efficacy of Mirabegron for Neurogenic Bladder Patients Phase 2/Phase 3
Recruiting NCT05380661 - Heart Rate Variability and Anxiety During Urinary Bladder Catheterization N/A
Recruiting NCT04193709 - Recovery of Bladder and Sexual Function After Human Spinal Cord Injury N/A
Completed NCT02582151 - Transcutaneous Peripheral Neuromodulation for Neurogenic Bladder N/A
Active, not recruiting NCT05232253 - Cystoealstometer (Bladder Monitor Device)-Home Use N/A
Completed NCT03405285 - Connected Catheter Clinical Feasibility Study( CFS) N/A
Completed NCT02673047 - Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder N/A
Completed NCT01773213 - Detrusor Contraction During the Ice-water-test N/A
Completed NCT01530620 - Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity Phase 3